TABLE OF CONTENTS
| | | | Volume 31, Issue 33 (August 2012) | | In this issue Original Articles Letter to the Editor
Also new AOP
| Advertisement | Optimal NGS library construction at LIGHTNING speed!
Create high-quality genomic libraries for any sequencing platform and achieve successful, cost-efficient next-generation sequencing experiments in 1/5th the time of competing systems. Diagenode’s Bioruptor Sonicator is proven as the shearing device of choice providing optimal yields, quality, and fragment size at the industry’s best value. Learn how Diagenode will maximize your sequencing results. |
|
| | | Advertisement | | | | | Original Articles | Top | | A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancerA Bonnomet, L Syne, A Brysse, E Feyereisen, E W Thompson, A Noël, J-M Foidart, P Birembaut, M Polette and C Gilles Oncogene 2012 31: 3741-3753; advance online publication, November 28, 2011; 10.1038/onc.2011.540 Abstract | Full Text | | | | Transtumoral targeting enabled by a novel neuropilin-binding peptideL Roth, L Agemy, V R Kotamraju, G Braun, T Teesalu, K N Sugahara, J Hamzah and E Ruoslahti Oncogene 2012 31: 3754-3763; advance online publication, December 19, 2011; 10.1038/onc.2011.537 Abstract | Full Text | | | | Synthesis of cytochrome c oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell deathC Wanka, D P Brucker, O Bähr, M Ronellenfitsch, M Weller, J P Steinbach and J Rieger Oncogene 2012 31: 3764-3776; advance online publication, November 28, 2011; 10.1038/onc.2011.530 Abstract | Full Text | | | | The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4S J Lubbe, A M Pittman, B Olver, A Lloyd, J Vijayakrishnan, S Naranjo, S Dobbins, P Broderick, J L Gómez-Skarmeta and R S Houlston Oncogene 2012 31: 3777-3784; advance online publication, December 12, 2011; 10.1038/onc.2011.564 Abstract | Full Text | | | | Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progressionL Mao, J Ding, A Perdue, L Yang, Y Zha, M Ren, S Huang, H Cui and H-F Ding Oncogene 2012 31: 3785-3795; advance online publication, November 28, 2011; 10.1038/onc.2011.536 Abstract | Full Text | | | | The immediate early gene Ier2 promotes tumor cell motility and metastasis, and predicts poor survival of colorectal cancer patientsA Neeb, S Wallbaum, N Novac, S Dukovic-Schulze, I Scholl, C Schreiber, P Schlag, J Moll, U Stein and J P Sleeman Oncogene 2012 31: 3796-3806; advance online publication, November 28, 2011; 10.1038/onc.2011.535 Abstract | Full Text | | | | Acetylation controls Notch3 stability and function in T-cell leukemiaR Palermo, S Checquolo, A Giovenco, P Grazioli, V Kumar, A F Campese, A Giorgi, M Napolitano, G Canettieri, G Ferrara, M E Schininà, M Maroder, L Frati, A Gulino, A Vacca and I Screpanti Oncogene 2012 31: 3807-3817; advance online publication, November 28, 2011; 10.1038/onc.2011.533 Abstract | Full Text | | | | MiR-27b targets PPARγ to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cellsJ-J Lee, A Drakaki, D Iliopoulos and K Struhl Oncogene 2012 31: 3818-3825; advance online publication, November 28, 2011; 10.1038/onc.2011.543 Abstract | Full Text | | Letter to the Editor | Top | | IDH mutation status in prostate cancerA F Ghiam, R A Cairns, J Thoms, A Dal Pra, O Ahmed, A Meng, T W Mak and R G Bristow Oncogene 2012 31: 3826; advance online publication, November 28, 2011; 10.1038/onc.2011.546 Full Text | | | | Advertisement | |
The Arab world has a rich history of scientific breakthroughs. Ensure you're part of the scientific and medical community gaining access to the latest research in the region.
Access Nature Middle East - your free portal for news, features, jobs and events in the Arabic speaking world.
www.nature.com/nmiddleeast
Follow us: Facebook, Twitter, Google + |
| | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | |
| | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | | |
|
|
No comments:
Post a Comment